[13] [16] For patients taking GLP-1/GIP medicinesparticularly those on concurrent metformin, following restricted diets, or with pre-existing malabsorption conditions proactive monitoring and management of B12 status should be considered an integral component of comprehensive care
in-office doctors visits Self-diagnosis Self-administration Considering where compounded drugs should fit into the patient access conversation Discerning between clinical and cosmetic applications of GLP-1s Efficacy Impact Demand Side effects Responding to patient advocacy Policy development Distinguishing between actions taken to protect the patient vs
Williams reported that while central blockade of the GLP-1 system with ICV administration of exendin 939 blocked the actions of central but not peripheral GLP-1, peripheral (intraperitoneal) exendin 939 blocked the appetite-suppressing actions of peripheral, but not central GLP-1, indicating that the two systems do not depend on each other for activity
Thats because the pigment-producing cells (melanocytes) are still active
During aging, metabolic function gradually declines, leading to insulin resistance, fat accumulation, and insufficient energy metabolism
